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Nine replicate samples of peptides from soybean leaves, each spiked with a different
concentration of bovine apotransferrin peptides, were analyzed on a mass spectrometer using
multidimensional protein identification technology (MudPIT). Proteins were detected from the
peptide tandem mass spectra, and the numbers of spectra were statistically evaluated for
variation between samples. The results corroborate prior knowledge that combining spectra
from replicate samples increases the number of identifiable proteins and that a summed
spectral count for a protein increases linearly with increasing molar amounts of protein.
Furthermore, statistical analysis of spectral counts for proteins in two- and three-way
comparisons between replicates and combined replicates revealed little significant variation
arising from run-to-run differences or data-dependent instrument ion sampling that might
falsely suggest differential protein accumulation. In these experiments, spectral counting was
enabled by PANORAMICS, probability-based software that predicts proteins detected by sets
of observed peptides. Three alternative approaches to counting spectra were also evaluated by
comparison. As the counting thresholds were changed from weaker to more stringent, the
accuracy of ratio determination also changed. These results suggest that thresholds for
counting can be empirically set to improve relative quantitation. All together, the data confirm
the accuracy and reliability of label-free spectral counting in the relative, quantitative analysis
of proteins between samples. (J Am Soc Mass Spectrom 2010, 21, 1534–1546) © 2010
American Society for Mass SpectrometryMultidimensional protein identification technol-ogy (MudPIT), a qualitative mass spectrome-try (MS) method for the detection of many
proteins in a sample, is becoming ever more quantita-
tive [1, 2]. Instrumentation improvements for mass
precision, sensitivity, selectivity, and speed, along with
advances in software and computational approaches,
are changing the ways that amounts of proteins are
measured relative to one another in a single sample or
between samples [1]. These quantitative applications
are enabling systems biology studies and have led to
broader understandings of protein dynamics in cells
[3–6].
Relative protein quantitation in MudPIT takes two
forms: labeled and label-free. Labels include isotopes or
isobaric tags that shift the mass of a labeled protein or
peptide. If two differentially labeled samples are ana-
lyzed concurrently, an expected shift in the mass spec-
trum can be observed for a parent or daughter ion from
one of the samples and the relative amounts of proteins
or peptides determined from the differential ion peak
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doi:10.1016/j.jasms.2010.05.001heights (ion signal strength), ion peak areas, or numbers
of tandem mass spectra produced [3, 7–13]. In the
label-free approaches, parent ion peaks, parent ion mass
counts, or numbers of tandem mass spectra can also be
used to determine amounts of protein or peptide in a
sample [4, 14–20]. However, label-free samples cannot
be analyzed concurrently in a mass spectrometer be-
cause there is no predictable mass shift to enable a
direct comparison. Therefore, while the label-free meth-
ods may be more convenient in that they save financial
or time costs associated with labeling, they are thought
to be less accurate than labeling methods [1]. In reality,
label and label-free methods are independently sup-
ported by empirical data that confirm their quantitative
accuracy within a relative context.
In this light, we have independently pursued a
label-free method of counting tandem mass spectra for
deducing protein accumulation changes between sam-
ples. Our decision to pursue a label-free method over
labeling was based on the difficulty of incorporating
isotopic labels into the metabolic cycles of live agricul-
tural pathogens and plants that we study and our lack
of resources for developing and using labeling chemis-
tries. Instead, we invented a software platform,
PANORAMICS, that allows us to analyze large amounts
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program to perform tandem mass spectral counting
[21]. We now regularly use MudPIT to identify hun-
dreds and thousands of proteins from pathogenic fungi
and their host plants and have used PANORAMICS to
perform spectral counting and show alterations in pro-
tein accumulation that may be associated with develop-
mental cues and disease resistance [4, 22].
To justify our approach in the past, we relied upon
the reports of others who demonstrated that tandem
mass spectral counts for standard protein samples can
rise linearly with increasing molar amounts of protein
over at least 2 orders of magnitude (log10) [15, 17, 20].
Now, to verify our own particular spectral counting
approach, we have analyzed different molar amounts of
bovine apotransferrin in the backgrounds of nine com-
plex but replicate mixtures of soybean peptides. We
expected that the experiments would allow us to test
three things: (1) whether our method could distinguish
a single statistically significant protein accumulation
change in the midst of a large background of proteins;
(2) whether there were any statistically significant
accumulation changes among background soybean
proteins—theoretically, there should be none and any
observed changes would be considered erroneous and
point to flaws in the method; (3) if altering rules for
selecting spectra for counting would produce quantita-
tive results that are more or less accurate than expected
values. The following results from these tests confirm
the reliability of spectral counting for the relative quan-
titative assessment of protein accumulation between
multiple samples using MudPIT.
Methods
Peptide Samples
Glycine max cv. Williams 82 was grown during the
summer months in an insect-free, controlled-environment
greenhouse. This variety is important because it is
the parent to many soybean production cultivars grown
in the U.S. and because its genome is sequenced [23].
The first, fully-opened trifoliate leaves from 3 to 4
wk-old plants 12 inches tall were collected from 50
plants. Leaves were frozen in liquid nitrogen and
ground in acetone/10% trichloracetic acid/0.07%
-mercaptoethanol. The slurry was centrifuged at
35,000  g and the pellet washed three times in ace-
tone/0.07% -mercaptoethanol. Proteins from 20 mg of
dried pellet were resolubilized in 8 M urea/100 mM
Tris-HCl pH 8.5/1% -dodecyl maltoside, filtered
through a 5 m membrane, precipitated in 25% tri-
chloracetic acid, centrifuged at 21,000  g and washed
three times in acetone. The final protein pellet was
resuspended in 8 M urea/100 mM Tris-HCl pH 8.5.
Protein concentrations were estimated by bicinchoninic
assay (Pierce, Rockford, IL, USA). Nine samples each
containing 1 mg soluble protein were reduced, carboxy-
amidomethylated, and digested with trypsin [24]. Thedigested samples were desalted using solid-phase ex-
traction with SPEC-PLUS PT C18 columns (Varian,
Lake Forrest, CA, USA). The samples were combined
and then equally divided into 1 mg protein aliquots
among nine separate vials. Different molar amounts of
tryptic digests of bovine apotransferrin (Michrom
Bioresources, Auburn, CA, USA) were added to the
vials.
Mass Spectrometry
Peptides from vials were separated on home-made 75
m i.d. fused-silica columns with a 5 m tip and packed
first with reverse phase C18 resin (Aqua, 5 m; Phe-
nomenex, Torrance, CA, USA) followed by strong cat-
ion exchange resin (Luna, 5 m; Phenomenex) [24]. A
12-step elution procedure consisting of step-wise in-
creasing concentrations of salt solution followed by
increasing gradients of organic mobile phase was used
[24]. Solvent flow was 200 nL/min and was controlled
with an Accela HPLC pump (Thermo Fisher Scientific,
Waltham, MA, USA) and with a T-split junction where
2100 V electricity was applied [24]. The eluent was
electrosprayed directly into the orifice of an LTQ-
Orbitrap XL mass spectrometer (Thermo Fisher Scien-
tific) controlled by Xcalibur 2.0.7 software (Thermo
Fisher Scientific). A parent-ion scan was performed in
the Orbitrap over the range of 400–1600 m/z at 30,000
resolution, with 500,000 automatic gain control (AGC),
500 ms ion injection time, and 1 scan. Lock-mass was
enabled [25]. Data-dependent MS2 was performed in
the linear ion trap with 10,000 AGC and 100 ms ion
injection times with 1 scan and on the 10 most
intense MS ions with a minimum signal of 1000. An
isolation width of 2 m/z and normalized collision
energy of 35% were used. Dynamic exclusion was
used with repeat count of 1, 30 s repeat duration, a
list of 500, list duration of 2 min, and exclusion mass
width of  0.7 Da.
Mascot Searching
MS2 spectrum data files were extracted from the raw
data with Bioworks 3.3.1 (Thermo Fisher Scientific)
using the parameters 600–4500 mass range, 1 group
scan, 1 minimum group count, and 5 minimum ion
counts. Sets of combined MS2 spectra were searched
with Mascot 2.2.04 [26]. Search parameters were for
tryptic digests, one possible missed cleavage, fixed
amino acid modification [57, C], variable amino acid
modifications [16, M], monoisotopic mass values,10
ppm parent ion mass tolerance, 0.8 Da fragment ion
mass tolerance and #13C  1 enabled. The searched
database consisted of soybean genome [23] protein
reference sequences (Glyma1.pep.fa from www.
phytozome.net; 75,781 records), the apotransferrin
record (gi 2501351), and common contaminants (75,951
records total).
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Mascot output files were processed by PANORAMICS,
a probability-based program that determines the likeli-
hood that peptides are correctly assigned to proteins
[21]. PANORAMICS considers for each spectrum up to
10 ranking peptide matches made by Mascot with
Ions/Identity score differences not less than 10 and
calculates the probabilities that these matches are cor-
rect. Generally, peptide matches with higher Ions scores
receive higher probabilities while peptide matches with
lower Ions scores receive lower probabilities. However,
the database size and the length and charge state of
each peptide sequence are also factored. A probability
for a protein or a group of proteins with the same set of
matching peptides is then calculated from the corre-
sponding peptide probabilities. Generally, high protein
probabilities are a product of several high-scoring pep-
tide matches, but lower-scoring and lower-ranking pep-
tides can also contribute a smaller amount of probabil-
ity to protein identification. Full probability values for
distinct peptides (unique to a protein or group) are used
in protein probability calculations whereas portions of
the probabilities for shared peptides (those common to
different groups) are distributed across the sharing
groups such that greater portions are distributed to the
most probable proteins. As a result of the probability
calculations and the groupings, parsimony is achieved.
Protein groups were ultimately treated as single pro-
teins and we arbitrarily chose one record from the list of
all records in the group as the one to represent the
group. Proteins with probabilities  95% were consid-
ered for spectral counting.
Spectral Counting
PANORAMICS counted a spectrum assigned to a pep-
tide if an ion score produced a positive probability,
which required the Mascot Ions/Identity score differ-
ence to be not less than 10 and if the score was
top-ranking (note that the rule for counting only top-
ranking matches is different from the model for calcu-
lating probabilities where all ranking matches are con-
sidered). A distinct peptide count was based on the total
number of spectra satisfying the preceding criteria while a
shared peptide count was divided by the number of
protein groups in which it was shared. An experimental
version of PANORAMICS was also produced to count
spectra assigned to peptides regardless of Mascot Ion
score rank (ALLCOUNT), to count spectra to all peptides
with a top-ranking Mascot Ions score regardless the Ions/
Identity score difference (TOPCOUNT) and to count spec-
tra assigned to peptides if the Ions score was top-ranking
and if the Ions/Identity score difference was not less than
zero (IDENTCOUNT). Spectral counts assigned to each
peptide in an identified protein or protein group were
summed.Statistical Analysis
Quantitative analysis was limited to the same sets of
proteins identified between replicates or combinations
of replicates. A G-test was used to assess the statistical
differences between summed spectral counts for each
protein [17], with the hypothesis being that the summed
spectral count of any protein A was equal between
replicates or combinations. Normalization values were
the total sum of spectral counts for all considered
proteins in a replicate or combination of replicates. The
corresponding P value was calculated from 2 distribu-
tion with 1° of freedom for a two-way comparison or 2°
of freedom for a three-way comparison. The Benjamini
and Hochberg correction was applied such that only a
protein with P value  q(j/t) was considered as having
differential summed spectral counts between samples.
In this equation, j is the rank of the protein in the list of
t proteins sorted in ascending order by P value and q is
the false discovery rate. In essence, the correction uses
the P value to establish a false discovery rate q. Here, q
was set for false discovery rates of 5% and 1%. Alter-
natively, a t-test was used to compare the normalized
summed spectral counts for a protein across three
replicates to the same in another set of three replicates.
Normalization values were the total sum of spectral
counts for all considered proteins in a replicate. The
Benjamini and Hochberg correction was also applied to
the t-test P values.
Theory
Rationale for Quantitative Method
Our relative quantitative proteomic method begins with
digesting proteins in a sample and generating peptide
tandem mass spectra. The spectra are then matched to
candidate peptide sequences by Mascot and the pep-
tides are “reassembled” into proteins using the proba-
bility model of PANORAMICS. Proteins exceeding a
defined probability cut-off are considered significant;
we typically choose 95%. Then, spectral counts for the
peptides comprising each protein are summed to gen-
erate a protein spectral count. Summed spectral counts
for the same protein identified between samples can
then be compared with each other, and a G-test is used
to determine significant differences. Several decisions
pertaining to this method are detailed:
1. We sum the spectral count for all peptides compris-
ing a protein as opposed to counting one or a few
representative “proteotypic” peptides for a protein
[27, 28]. Our choice logically fits the PANORAMICS
probability model that determines which proteins
are then quantitatively examined: Protein probabil-
ities are a product of all significant peptide matches
that contribute to protein identification. Therefore,
the spectra for those peptides are counted. A com-
parison of counting spectra of all significant pep-
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2. PANORAMICS does not count all spectra submitted
to and analyzed by Mascot. A spectrum is counted if
its corresponding Mascot Ions score produced a
positive peptide probability, if the Mascot Ions
score was top-ranking among possible candidate
peptides and if the Mascot Ions score/Identity
score difference was not less than 10. For exam-
ple, PANORAMICS does not count a spectrum if
the Ions score for a peptide match is 28 and the
Identity score is 40. A study on the effects of
alternative counting methods is presented below.
3. Because of random sampling effects associated with
high-throughput mass spectrometry [15], it is usu-
ally difficult to determine if the absence of any
protein from a dataset is a result of it not being in
the sample or just a by-product of the chance of not
detecting it. The latter is most likely for these
experiments, as we show later. Additionally, in
these experiments, a protein could be identified
with a probability of 95.1% in one sample, but 94.9%
in another. As a result of a cut-off for accepting
proteins identified with probabilities of 95% or
greater, the protein would remain in the first dataset
but not the other. In the past, we have accepted
lower protein identification probabilities as long as
there was a higher probability for identification in
another sample [4]. Here, however, we have limited
our analysis of spectral count variability to proteins
common between datasets and exceeding the 95%
cut-off.
4. Spectra can be matched to peptide sequences that
are distinct to a protein or shared among a set of
proteins (usually members of a family of proteins)
[29]. Logically, if a peptide is shared among two
different protein groups A and B and there are two
spectral counts, then the counts could be distributed
all to A, all to B, or split between A and B if A and
B coexist in the sample. Unfortunately, because the
peptide organization and distribution information is
lost upon digestion, there is no way to know how
the counts should be truly assigned. Several labs
have experimented with distributing counts of
shared peptides across proteins based on estima-
tions [30–33], yet these schemes rely on best
guesses. However, these studies have shown that
relative protein quantitation is more accurate when
shared peptides are included in the counting
scheme in some fashion. With these findings in
mind, we have decided to include spectral counts
for shared peptides but divide the count by the
number of protein groups in which the shared
peptides appear, to prevent shared peptides from
being counted more than once. This unbiased dis-
tribution creates several circumstances that should
be noted. Assume protein group A with probability
97% and protein group B with probability 94% share
a peptide. In this study, A is considered for analysisbut B is not because of the 95% cut-off. However, the
shared peptide count for A is still divided by 2 even
though B is no longer considered in the dataset.
While it may be possible to reassign the remaining
count of the shared peptide in B to A, we do not do
so for the sake of simplicity. As a result, possibly a
slight “under-counting” error is created for peptide
A. We then assume this under-counting error is
relegated to the protein group(s) that shares the
peptide. Certainly, this potential error is mini-
mized in protein groups with a preponderance of
distinct peptides. For protein groups preponder-
ant with shared peptides, these proteins are
highly homologous and may have nearly indistin-
guishable summed spectral counts as a result,
despite the over-count. If there are differences,
these should theoretically be predicated on the
counts of any distinct peptides. For this study, we
remain consistent with the counting of shared
peptides, but recognize that this topic is worthy of
future consideration.
5. We evaluate statistical differences between summed
spectral counts for common proteins between sam-
ples using a G-test. The G-test has a number of
features that make it appealing for analyzing
MudPIT data: (a) multiple MudPIT analyses are often
required to overcome sampling limitations inherent
to shotgun mass spectrometry [15, 34]. By pooling
the spectra from the replicate analyses and perform-
ing a unified Mascot search, the number of peptides
associated with each protein increases (thereby in-
creasing spectral count as well) and the total num-
ber of proteins identified increases too. The draw-
back is that means and variances of spectral counts
cannot be estimated for proteins among the repli-
cates once files are combined. This in turn eliminates
the use of statistical analyses that rely on these
values to make comparisons. However, the G-test
does not need to estimate the means and variances,
but instead directly tests a null hypothesis that an
observed count results from sampling from a distri-
bution of counts in a population. Clearly, combining
datasets favors the G-test. (b) The G-test considers
population size, and spectral counts are normalized
to the totals for the datasets as part of the analysis.
Therefore, it is not necessary to normalize to any
single reference standard. (c) Some statistical tests
are limited to pair-wise comparisons, but the G-test
can be generalized to suit examining multiple con-
ditions [17]. This favors proteomics where several
samples subjected to different treatments might be
compared with a control. The following results will
show the reliability of the G-test in determining
significant differences and its advantage over a
t-test. Readers interested in comparisons between
other statistical tests used to evaluate differences in
spectral counts are referred to Zhang et al. 2006 [17].
6. Finally, in this study the soybean replicate samples
analyzed were theoretically equivalent except for
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apotransferrin. Therefore the samples were theoret-
ically free from uncontrolled variability. Further-
more, the data for the samples was treated equiva-
lently except where noted below. However, there
were other factors that were not entirely controllable
that had the potential to affect spectral counts. To
our best ability, we used good standard pipetting
practices and calibrated instruments to reduce error,
packed all columns with the same preparation of
separation materials, and packed the columns with
tolerances no less than 0.5 cm and no greater than 1
cm to the lengths describe above. The mass spec-
trometer was tuned and all experiments run subse-
quently with respect to the same tune file parame-
ters. Other factors that had the potential to impact
count, but remained static for these experiments,
were number of ions selected for tandem mass
spectrometry and parameters for dynamic exclu-
sion. While our parameters for dynamic exclusion
were based on those that have been optimized for
relative quantitation by spectral counting [35], pos-
sibly future research could be performed to refine
these parameters or those for ion selection.
Results and Discussion
Proteins from Nine Replicate Samples
Each of the nine replicate soybean peptide samples was
spiked with a different molar amount of tryptic pep-
tides from a bovine apotransferrin tryptic digest, rang-
ing from 0.005 to 2.5 pmol and analyzed by MudPIT.
We found that the summed spectral counts for apo-
transferrin increased linearly with the amounts of apo-
transferrin between 0.5 and 2.5 pmol (Figure 1; Table 1,
column “	 spectral count apotransferrin”). A best fit
line with R2  0.9585 revealed consistent reproducibil-
ity of spectral counts between duplicated analyses on
0.5, 1.0, and 2.5 pmolar amounts (Figure 1). Apotrans-
ferrin was not detected above 95% probability in sam-
ples with 0.005 or 0.05 pmol, which establishes our
lower limit of detection between 0.05 and 0.5 pmol. This
is similar to Old et al. [20], who examined an apotrans-
ferrin dynamic range between 0.05 and 5.0 pmol and
found the lower limit of detection to be between 0.05
and 0.3 pmol. In addition, Old et al. [20] observed a loss
of spectral count linearity above 30. This was not the
case for us and is likely due to the faster duty-cycle of
our mass spectrometer and our adjusted dynamic ex-
clusion parameters.
A more interesting picture emerged when evaluating
the soybean proteins present in the samples. Despite the
samples theoretically being comprised of the same
soybean peptide mixtures, the numbers of proteins
found above a 95% confidence level ranged from 1474
to 2127 proteins between replicates (Table 1, column
“proteins  95%”). This run-to-run variability is mostlikely a result of ion sampling variability inherent to
MudPIT [15, 34].
While the numbers of proteins detected between
samples varied by 30%, the total numbers of spectra
collected in each replicate run varied only by 10%
(ranging from 252,035 to 276,007 spectra; Table 1, col-
umn “total spectra collected”). In addition, there was no
perfect correlation between number of proteins found
and total number of spectra collected. In fact for repli-
cate no. 5, there was an instrument/software commu-
nication glitch in five of the separation steps of that run
that prevented the recording of all spectra observed. We
included this imperfect run in this analysis as a way of
deliberately introducing variability. Interestingly, while
replicate no. 5 had the smallest number of total spectra
collected, it did not yield the smallest number of iden-
tified proteins. Rather, replicate no. 7 yielded the small-
est number of proteins, yet it had nearly 10,000 more
spectra than replicate no. 5. Therefore, other factors
besides total numbers of spectra collected, e.g., total
numbers of good peptide spectra generated, have more
direct bearing on number of total proteins detected.
When spectra from the replicates were combined
(pooled), the number of identified proteins increased
(Table 1, column “proteins  95%”). This demonstrates
the benefit to protein discovery when combining spec-
tra from replicate runs. As proteins from each of nine
replicates were sequentially combined, the numbers of
new proteins increased by 200 per replicate to a final
total of 3502 (Figure 2). The saturation point for protein
discovery was not reached even after nine replicate
analyses, meaning that additional analyses would be
Figure 1. Relationship between number of spectra associated
with peptides for apotransferrin and the molar amount of apo-
transferrin added to a sample. Soybean peptide samples were
spiked with 0.005, 0.05, 0.5, 1.0, and 2.5 pmol apotransferrin and
were analyzed by MudPIT twice (except 0.005, which was only
analyzed once). Apotransferrin at 0.005 and 0.05 pmolar amounts
were not resolved by this method. Spectral count values for the
pairs of samples with 0.5, 1.0, and 2.5 pmol apotransferrin in Table
1 correspond with this figure.necessary for deeper coverage of leaf proteins.
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Since it was clear that there was variability between
replicates in terms of proteins discovered, we were
concerned that this variability might also affect the
accuracy of spectral counting. Because label-free spec-
tral counting relies on samples being analyzed consec-
utively rather than concurrently, we worried that it
might be difficult to distinguish the error inherent to the
run-to-run variability from bona fide changes among
true experimental samples.
To test whether ion sampling error could adversely
influence spectral counting, we performed two- and
three-way comparisons of replicates using a G-test.
There was not full congruency of overlapping proteins
between replicates. For example, replicates no. 1 and
no. 6 had 1829 and 1908 proteins, respectively, but there
were only 1374 proteins in common between them
(Table 2, column “common proteins”). These differ-
ences appear to be a product of run-to-run variability
(potential sources will be investigated in a later section).
Table 1. Protein and spectral count statistics for replicate and co
Soybean
replicate
Apotransferrin
pmol
Total spectra
collected
Proteins
95%a
 S
co
pr

1 0.5 276,007 1,829 2
2 0.05 272,263 1,796 2
3 0.005 270,060 1,474 1
4 0.5 270,991 1,539 2
5 0.05 252,035 1,542 2
6 2.5 255,497 1,908 2
7 1 262,736 1,516 2
8 1 261,060 1,740 2
9 2.5 266,927 2,127 2
23 0.055 542,323 2,019 4
12 0.55 548,270 2,271 4
45 0.55 523,026 2,071 4
24 0.55 543,254 2,057 4
15 0.55 528,042 2,161 4
37 1.005 532,796 1,878 4
28 1.05 533,323 2,297 4
47 1.5 533,727 1,929 4
36 2.505 525,557 2,225 4
39 2.505 536,987 2,418 4
56 2.55 507,532 2,198 4
16 3 531,504 2,366 4
123 0.555 818,330 2,430 6
125 0.6 800,305 2,508 6
134 1.005 817,058 2,380 6
137 1.505 808,803 2,365 6
458 1.55 784,086 2,470 6
785 2.05 775,831 2,361 6
456 3.05 778,523 2,533 6
367 3.505 788,293 2,423 6
289 3.55 800,250 2,808 7
692 5.05 794,687 2,828 7
nf  not found.
aProtein probability as determined by PANORAMICS.As for the overlapping proteins, eight exhibited differ-entially significant spectral counts when the false dis-
covery rate was set at 5% [Table 2, column “proteins
with different spectral counts (G-test, sig.  95%)”].
Since zero was theoretically expected, these proteins
with differential counts were falsely discovered by this
method. However, the overall false discovery rate,
empirically measured by dividing the number of falsely
discovered proteins by the total number of proteins for
which no variation was expected, was just 0.6% and
within the expected false discovery rate set by the
q-value [Table 2, “variance per common protein (sig. 
95%)”]. For several other combinations examined, be-
tween one and 39 proteins exhibited differential spec-
tral counts [Table 2, column “proteins with different
spectral counts (G-test, sig.  95%)”], and the empirical
false discovery rates ranged from 0.1% to 3.8% [Table 2,
column “variance per common protein (sig.  95%)”].
For the three-way comparisons, the sets of overlapping
proteins were generally smaller, as expected. However,
the number of proteins with significantly different
ned replicate files
ral
or
s
a
 Spectral
count
apotrans
ferrin
 Spectral
count ALL
COUNT
(proteins
95%)
 Spectral
count TOP
COUNT
(proteins
95%)
 Spectral
count IDENT
COUNT
(proteins
95%)
17 30,027 25,083 16,489
0 (nf) 30,041 25,113 14,422
0 (nf) — — —
14 28,830 24,205 15,318
0 (nf) — — —
60 33,816 28,190 18,551
36 29,018 24,375 15,230
37 — — —
69 — — —
0 (nf) — — —
18 — — —
16 — — —
15 — — —
19 — — —
36 — — —
38 — — —
50 — — —
60 — — —
69 — — —
62 — — —
77 — — —
18 — — —
20 — — —
31 — — —
53 — — —
53 — — —
75 — — —
76 — — —
96 — — —
107 — — —
130 — — —mbi
pect
unt f
otein
95%
1,774
2,018
8,827
0,671
0,540
4,456
0,873
3,200
6,079
1,759
4,654
2,478
3,864
3,360
0,714
6,343
2,669
4,345
6,075
6,113
7,292
4,685
6,557
3,668
3,890
7,179
7,195
8,284
6,656
3,760
4,884spectral counts rose somewhat, with the empirical false
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column “variance per common protein (sig.  95%)”].
Nonetheless, the average empirical false discovery rates
are in line with the preset 5% q-values; given the limited
number of trials, we believe the empirical false discov-
ery rates are very close to those predicted and con-
strained by the statistical tests.
Earlier, we showed that the numbers of proteins
detected increased as spectra from replicates were
pooled (Table 1, column “proteins  95%”). Hence, we
thought that pooling spectra from two or three repli-
cates and comparing pooled data to other merged
replicates would result in increased numbers of pro-
teins that were common between them. This was gen-
erally true, as combinations of two replicates had
between 1500 and 1700 proteins in common, and
combinations of three replicates had 1900 proteins in
common for two-way comparisons (Table 2, column
“common proteins”). The overlap was smaller for three-
way comparisons, but the number of overlapping pro-
teins still increased as more spectra were pooled. We
therefore assumed that pooling spectra from replicates
might give the effect of increased statistical sampling
which could theoretically reduce the amount of varia-
tion caused by ion sampling. Surprisingly, spectral
count variability did not bottom out. Instead, empirical
false discovery rates remained at the levels predicted by
the statistical tests [Table 2, column “variance per
common protein (sig.  95%)”]. In other words, com-
bining spectral datasets may have reduced spectral
count variability for some proteins, but the addition of
other proteins to the dataset kept the overall false
discovery rate within an expected amount of error.
We sought to determine if there was any counting
bias associated with proteins falsely discovered as
having significantly different spectral counts. We
examined the distribution of counts for all 1716
Figure 2. Number of proteins identified at 95% confidence
level with each added replicate file. As spectral datasets from each
replicate run are combined and then analyzed by Mascot and
PANORAMICS, the number of proteins identified increases, thus
attributing to the benefit of performing replicate analyses and
combining spectral datasets. This graph suggests that more than
nine replicate analyses would be required for comprehensive
soybean protein identification from these replicate samples.proteins common to 692, 137 and 458combined replicate files (Figure 3). Only seven pro-
teins had summed spectral counts greater than 500;
81% of proteins had summed spectral counts less
than 51, with 10–25 counts being most prevalent
[note that the spectral count linearity of apotrans-
ferrin could be determined with 69 or fewer counts
(also see below)]. Next, we evaluated the distribution
of spectral counts for the 84 proteins with signifi-
cantly different spectral counts in the 692 file.
Most of the proteins with variable counts had counts
51 or greater (Figure 3). This means that while the
false discovery rate applies to the dataset as a whole,
error is mostly centralized to proteins having 51
counts or more. Since most of the proteins evaluated
have counts less than 51, it can be expected that these
proteins exhibit less statistical deviation.
Statistical Analysis of True Variation
The ability to significantly evaluate the different
amounts of apotransferrin between samples was also
examined. Spectral count ratios as small as 1 to 3.5 were
found to be significantly different (q  0.01), but ratios
of 1 to 1.7 were not (Table 2, columns “apotransferrin
summed spectral count” and “apotransferrin count
ratio”). Our smallest ratios are better than the smallest 1
to 5 ratios most accurately measured in prior studies
[15, 17, 20]. When replicates were combined and exam-
ined in three-way comparisons, the discriminating
power was more refined. Ratios of 1 to 3.5 to 2 were
found to be significantly different, as were ratios 1 to 0.9
to 3.3, ratios 1 to 2.4 to 4.2, and ratios 1.4 to 1 to 2 [Table
2, columns “apotransferrin summed spectral count”
and “apotransferrin count ratio”]. Hence, more subtle
spectral count differences were resolvable in three-way
comparisons, but the improved discrimination was also
associated with slightly increased empirical false dis-
covery rates.
It should be noted that while these spectral counts
ratios were found to be significantly different, the
observed ratios did not accurately represent the true
molar ratios of apotransferrin spiked into the samples.
For example, a 1 to 5 M difference was observed as a 1
to 3.5 spectral count ratio, while a molar difference of 1
to 5 to 2 was measured as a 1 to 4.3 to 2.6 spectral count
ratio (Table 2, columns “apotransferrin count ratio” and
“apotransferrin molar ratio”). In other words, the ob-
served spectral count ratios were slightly suppressed
compared with the actual molar ratios of apotrans-
ferrin. Likely, dynamic exclusion results in spectral
count suppression, but an alternative cause based on
the spectral counting scheme will be presented later.
Notwithstanding, the G-test was sufficient for distin-
guishing as low as 3.3-fold spectral counts changes in
two-way comparisons and 2-fold changes in three-way
comparisons.
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As mentioned earlier, it has been demonstrated that the
G-test is a useful statistical method for analyzing dif-
ferential spectral counts between multiple samples [17].
To further confirm the rigors of the G-test, we tested
its ability to balance disparate datasets of spectral
counts that might arise as result of sample handling
errors or sample loading mistakes. Theoretically,
some balance can be restored statistically by normal-
ization. To test this, we compared a single replicate to
two merged replicates (Table 2, replicates 4 to 12, 2
to 36, and 7 to 16), such that the merged file
contained nearly double the number of spectra. In
this instance, if the G-test normalizes correctly, there
should be no significant differences found. Three out
Table 2. Protein and spectral count statistics for comparisons be
Replicates
Common
proteins
Total s
comm
Two-way comparisons
1 to 2 1329 18,869/19,2
1 to 6 1374 19,323/21,3
2 to 7 1040 17,359/17,7
3 to 4 1167 16,976/18,3
4 to 5 1030 17,283/17,1
6 to 7 1193 20,003/18,8
4 to 12 1334 19,346/36,6
2 to 36 1544 20,898/39,4
7 to 16 1316 19,165/37,3
12 to 56 1662 39,506/41,5
12 to 36 1712 40,084/40,1
45 to 36 1637 38,635/39,8
56 to 37 1469 39,221/36,5
24 to 36 1600 39,836/39,3
23 to 47 1507 37,217/38,3
123 to 456 1905 59,398/61,8
1,2,3 to 4,5,6 774 14,806/15,0
14,879/16
125 to 367 1900 59,495/60,2
1,2,5 to 3,6,7 793 14,280/13,3
14,423/15
137 to 456 1877 58,510/61,3
1,3,7 to 4,5,6 729 14,937/15,2
16,332/15
Three-way comparisons
1 to 2 to 3 1163 18,280/18,7
1 to 2 to 5 1077 17,413/17,7
1 to 6 to 7 1070 17,197/19,0
2 to 4 to 6 1069 17,921/17,8
4 to 6 to 7 988 17,147/18,3
12 to 56 to 37 1343 36,087/37,9
24 to 15 to 36 1378 37,163/36,1
12 to 36 to 56 1556 38,440/38,7
12 to 45 to 36 1468 37,979/37,1
39 to 28 to 47 1433 37,874/38,8
134 to 785 to 692 1683 55,399/58,8
456 to 137 to 289 1733 59,440/56,5
692 to 137 to 458 1716 62,866/56,3
*Apotransferin; nf  not found; NA  not applicable.of three tests confirmed that this was indeed the case.The empirical false discovery rates of 0.1%, 0.6%, and
2.0% were within the predicted range and were
similar to those observed in the one-to-one compari-
sons [Table 2, column “variance per common protein
(sig.  95%)”].
The G-test was also compared with the t-test in terms
of statistical reliability for evaluating spectral counts.
The t-test allows the comparison of two conditions, but
requires that each condition have at least three repli-
cates to estimate means and variances. Therefore, we
were not able to evaluate replicates on a one-to-one or
two-to-two basis like we did with the G-test. This in
itself points to the advantage of the G-test since only
single replicates were needed to statistically resolve
apotransferrin spectral count differences in two- and
n replicate and combined replicate files
a 95%
roteins
Proteins with different
spectral counts
(G-test, sig. 95%)
Variance per
common protein
(sig. 95%)
1 0.001
8 0.006
3 0.003
2 0.002
39 0.038
34 0.028
2 0.001
10 0.006
26 0.020
81 0.049
11 0.006
15 0.009
118 0.080
31 0.019
14 0.009
41 0.022
,814/14,967/ — —
16 0.008
,793/14,453/ — —
27 0.014
,130/13,990/ — —
,159 7 0.006
,673 39 0.036
,795 26 0.024
,006 62 0.058
,539 74 0.075
,244 116 0.086
,805 61 0.044
,340 53 0.034
,143 25 0.017
,831 39 0.027
,385 122 0.072
,481 59 0.034
,729 84 0.049twee
pectr
on p
89
70
48
71
00
00
79
40
63
28
29
28
94
03
55
07
50/13
,008
79
69/14
,468
94
40/15
,428
00/17
02/17
05/17
24/19
00/17
30/35
45/36
85/40
49/38
84/37
43/62
50/62
77/58three-way comparisons (Table 2).
1542 COOPER ET AL. J Am Soc Mass Spectrom 2010, 21, 1534–1546Furthermore, when constrained to comparing a set of
three replicates to another set of three replicates by the
t-test, there were many proteins not found across all six
replicates. These proteins could not be evaluated by the
t-test because a mean and variance could not be calcu-
lated when a protein was missing in any one replicate.
Given this constraint of analyzing proteins found across
all six replicates, the number of proteins was half of
what could be analyzed by the G-test [Table 2, column
“common proteins” for replicates 1,2,3 to 4,5,6; 1,2,5 to
3,6,7 and 1,3,7 to 4,5,6]. Nevertheless, no variation in
spectral counts was observed for soybean proteins as
measured by the t-test [Table 2, column “proteins with
different spectral counts (t-test, sig.  95%)”].
To evaluate true count differences, we turned to
Table 2. Continued
Proteins
with different
spectral counts
(G-test, sig. 99%)
Variance per
common
protein
(sig. 99%)
Proteins with
different spectral
counts
(t-test, sig. 95%)
1 0.001 — 17 ver
6 0.004 — 17 ver
2 0.002 0 (nf)
2 0.002 — 0 (nf)
18 0.017 — 14 ver
8 0.007 — 60 ver
1 0.001 — 14 ver
7 0.005 — 0 (nf)
9 0.007 — 36 ver
42 0.025 — 18 ver
6 0.004 — 18 ver
9 0.005 — 16 ver
63 0.043 — 62 ver
19 0.012 — 15 ver
5 0.003 — 0 (nf)
24 0.013 — 18 ver
— — 0 not in
13 0.007 — 20 ver
— — 0 not in
14 0.007 — 53 ver
— — 1* 15,16,
4 0.003 — 17 ver
24 0.022 — 17 ver
10 0.009 — 17 ver
34 0.032 — 0 (nf)
35 0.035 — 14 ver
68 0.051 — 18 ver
39 0.028 — 15 ver
33 0.021 — 18 ver
16 0.011 — 18 ver
20 0.014 — 69 ver
57 0.034 — 31 ver
30 0.017 — 76 ver
47 0.027 — 130 veapotransferrin. But, because apotransferrin was notamong proteins with probabilities  95% in all repli-
cates, we inserted mock spectral counts in the files
missing them. Under this contrived circumstance, the
t-test determined the apotransferrin spectral count ra-
tios of 1 to 3.8 to be statistically different (Table 2,
replicate 1,3,7 to 4,5,6, column “apotransferrin summed
spectral count”). This discrimination power agrees with
the G-test in similar circumstances.
We conclude that the G-test is statistically rigorous
for determining differential spectral counts in two- and
three-way comparisons. In addition, the G-test allowed
us to combine spectra from different samples, enabling
the evaluation of twice as many proteins as the t-test
while maintaining reasonable control of the false dis-
covery rate. Finding significant differences among a few
otransferrin summed
spectral count
Apotransferrin
count ratio
Apotransferrin
molar ratio
0 (nf) NA 1:0.1
60 (sig. 99%) 1:3.5 1:5
us 36 NA 0.1:1
us 14 NA 0.01:1
0 (nf) NA 1:0.1
36 (not sig. 95%) 1.7:1 5:2
18 (not sig. 95%) 1:1.3 1:1.1
NA 0.1:5
77 (not sig. 95%) 1:1.9 2:6
62 (sig. 99%) 1:3.4 1.1:5.1
60 (sig. 99%) 1:3.3 1.1:5
60 (sig. 99%) 1:3.8 1.1:5
36 (not sig. 95%) 1.7:1 5.1:2
60 (sig. 99%) 1:4 1.1:5
us 50 NA 0.1:3
76 (sig. 99%) 1:4.2 1.1:6.1
NA NA
96 (sig. 99%) 1:4.8 1.2:7
NA NA
76 (not sig. 95%) 1:1.4 1:2
rsus 60,61,62 (sig. 99%) 1:3.8 1:5 (mock)
0 (nf) versus 0 (nf) NA 1:0.1:0.01
0 (nf) versus 0 (nf) NA 1:0.1:0.1
60 versus 36 (sig. 99%) 1:3.5:2.1 1:5:2
us 14 versus 60 NA 0.1:1:5
60 versus 36 (sig. 99%) 1:4.3:2.6 1:5:2
62 versus 36 (sig. 99%) 1:3.4:2 1.1:5.1:2
19 versus 60 (sig. 99%) 1:1.3:4 1.1:1.1:5
60 versus 62 (sig. 99%) 1:3.3:3.4 1.1:5:5.1
16 versus 60 (sig. 99%) 1:0.9:3.3 1.1:1.1:5
38 versus 50 (not sig. 95%) 1.8:1:1.3 5:2.1:3
75 versus 130 (sig. 99%) 1:2.4:4.2 2:4.1:10.1
53 versus 107 (sig. 95%) 1.4:1:2 6.1:3:7.1
53 versus 53 (sig. 99%) 2.5:1:1 10.1:3:3.1Ap
sus
sus
vers
vers
sus
sus
sus
to 60
sus
sus
sus
sus
sus
sus
vers
sus
all 6
sus
all 6
sus
17 ve
sus
sus
sus
vers
sus
sus
sus
sus
sus
sus
sus
sus
rsussamples has important consequences in terms of biolog-
abundant proteins.
nf  not found.
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precious samples.
On Proteins Unique to a Replicate
While there appears to be little statistically significant
summed spectral count variability between the same
proteins found between replicates, there remains a
portion of proteins left unstudied that are found in
some replicates but not others. For example, replicates
no. 3 and no. 4, respectively, had 1474 and 1539 detected
with a probability of 95% or greater, but only 1167
proteins were common between them. This means that
307 proteins were unique to replicate no. 3 and 372 were
unique to replicate no. 4. Because biological study
would be improved if the amount of overlap could be
greater, we sought for a reason to explain why some
proteins are only found in one sample but not another.
One possible reason would be the probability cut-offs
imposed. But when we examined the set of proteins
from replicate no. 3 identified at a probability level
between 95% and 80%, only 97 of the unique proteins
from replicate no. 4 were found. Thus, lower scoring
can only account for about a third of the differences.
Next, we evaluated the summed spectral counts for
the unique proteins to see if there was a difference in
the magnitude of counts for unique proteins versus
common proteins. More than 88% of the proteins from
replicate no. 4 had summed spectral counts less than 10.
Contrasted to Figure 3, where only 25% of common
proteins had summed spectral counts less than 10, it is
plausible that infrequent observation of peptides ex-
plains why some proteins are found in one replicate but
not another. To take it further, we examined the
ting schemes for comparisons between replicate and combined
NT

PANORAMICS
proteins with
different spectral
counts (G-test,
sig.  95%)
ALLCOUNT
proteins with
different spectral
counts (G-test,
sig.  95%)
TOPCOUNT
proteins with
different spectral
counts (G-test,
sig.  95%)
56 1 12 11
85 7 39 11
96 3 14 9
85 34 73 46
35/ 74 125 85
99/ 62 129 77Figure 3. Distribution of summed spectral counts for all proteins
common between combined replicates 692, 137, and
458 and those that had significantly different summed spectral
counts. Proteins with summed spectral counts were binned into
the spectral count groups shown. The percentage of all proteins
(95% probability) common to the combined replicate datasets
that fall into each bin are shown in black. Percentages of a subset
of proteins with statistically different spectral counts between
combined replicates are shown in gray. The figure shows that the
distribution of proteins with statistically different spectral counts
is not the same as that for the entire dataset. This suggests that
most spectral count variation is observed among the most highlyTable 3. Protein and spectral count statistics of altered spectral coun
replicate files
Replicates
compared
Common
proteins
Spectra
ALLCOUNT
(proteins 
95%)
Spectra
TOPCOUNT
(proteins 
95%)
Spectra
IDENTCOU
(proteins
95%)
1 to 2 1329 25,512/26,011 21,695/22,019 14,533/12,7
1 to 6 1374 26,189/29,039 22,273/24,704 15,411/13,8
2 to 7 1040 23,392/24,252 19,805/20,670 11,609/13,1
6 to 7 1193 27,044/25,888 22,983/21,976 15,411/13,8
4 to 6 to 7 988 23,614/24,671/
23,955
20,013/20,956/
20,454
12,836/14,1
13,047
2 to 4 to 6 1069 23,788/24,385/
25,291
20,096/20,640/
21,455
11,785/13,1
14,461
1544 COOPER ET AL. J Am Soc Mass Spectrom 2010, 21, 1534–1546numbers of shared and distinct peptides used to iden-
tify the unique proteins in replicate no. 4. There were
312 proteins identified by more distinct peptides than
shared peptides; 263 had no shared peptides at all, and
215 were solely identified by single distinct peptides.
Taken together, these numbers suggest that these
unique proteins were predominantly identified by sin-
gle peptides at low abundance. Since the replicates that
we evaluated were theoretically equivalent, it would
stand to reason that run-to-run variability inherent to
MudPIT, such as subtle peptide separation differences
of each hand-made column and instrument ion selec-
tivity based on second-to-second fluctuations of ions in
traps, may sufficiently explain why certain peptides at
low abundance can be found in one replicate but not
another. Clearly, as previously discussed, and delin-
eated in Tables 1 and 2, and illustrated in Figure 2, some
of this variation can be tempered by pooling spectra
from replicate runs which effectively increases the num-
ber proteins that overlap between two sets of data.
On Methods of Counting
PANORAMICS was originally designed to provide a
solution for determining which sets of peptide spectra
most likely identify a given protein [21]. Its ability to
report the counts of peptide spectra was added only
after we realized the program may also enable this kind
of quantitative analysis. Hence, the spectral counting
scheme was predicated on the probability model for
identifying proteins. As a result, this created a unique
basis for counting. Unlike other approaches where
only peptides exceeding a high match score or prob-
ability threshold are counted for each protein [36],
PANORAMICS counts high and low scoring spectra
because even low-scoring spectra have some small
probability of correctly identifying a protein. In addi-
Table 3. Continued
IDENTCOUNT
proteins with
different spectral
counts (G-test,
sig.  95%)
Apotransferrin spectra
and ratio
PANORAMICS
Apotransferrin sp
and ratio ALLCO
22 17 versus 0 (nf) 22 versus 0 (nf)
17 versus 60 22 versus 74
6 (sig.  99%) (sig.  99%)
[1:3.5] [1:3.4]
33 0 (nf) versus 36 0 (nf) versus 45
60 versus 36 74 versus 45
21 (not sig.) (not sig.)
[1.7:1] [1.6:1]
14 versus 60 versus 36 17 versus 74 vers
46 (sig.  99%) (sig.  99%)
[1:4.3:2.6] [1:4.4:2.6]
80 0 (nf) versus 14 0 (nf) versus 17
versus 60 versus 74tion, when Mascot matches more than one peptide
sequence to a spectrum (up to 10 possible ranked
sequences), PANORAMICS calculates probabilities for
each match. Because of the probability model, these
different peptide sequences for the same spectrum are
assigned to separate protein groups with different prob-
abilities of identification attributed to them. While this
is logical in terms of probability, we implemented a rule
to count only the top-ranking matches to prevent any
spectrum matched to multiple peptides in the probabil-
ity model from being counted more than once (note that
this is different from the rule of dividing the counts of
shared peptides to prevent their overcounting).
Clearly, just as we were able to establish a set of rules
for our counting method, it is possible to design other
counting schemes too. These alternative schemes may
result in different counting results. For example, the
Yates lab counts spectra if the top-ranked peptide
match scores do not exceed a false-positive rate of 5% as
determined by reverse database searching [37]. Interest-
ingly, setting such a threshold may lead to an under-
count. For example, spectra that fall just below the
threshold are not counted even if the match is rea-
sonable for identification. This could happen with
PANORAMICS as well. Imagine if spectrum 1 matches
peptide A with an Ions/Identity score difference of 5
and the next consecutive spectrum 2 also matches
peptide A but with an Ions/Identity score difference
of 12. In this case, spectrum 1 is counted by
PANORAMICS but spectrum 2 is not. Possibly, spec-
trum 1 and spectrum 2 represent stronger and weaker
fragmentation patterns for the same peptides and
that the real count is 2. But because of the threshold,
the count for this peptide is under-reported. This type
of undercount can occur regardless if one uses
PANORAMICS or the Yates’ lab method.
a Apotransferrin spectra
and ratio TOPCOUNT
Apotransferrin
spectra and
ratio
IDENTCOUNT
Apotransferrin
molar ratio
22 versus 0 (nf) 9 versus 0 (nf) 1:0.1
22 versus 69 9 versus 53
(sig.  99%) (sig.  99%) 1:5
[1:3.1] [1:5.9]
0 (nf) versus 42 0 (nf) versus 19 0.1 to 1
69 versus 42 53 versus 19
(not sig.) (sig.  95%) 2.5:1
[1.6:1] [2.8:1]
5 16 versus 69 versus 42 5 to 53 to 19
(sig.  99%) (sig.  99%) 1:5:2
[1:4.3:2.6] [1:10.6:3.8]
0 (nf) versus 16 vs. 0 (nf) versus 5 0.1:1:5
69 versus 53ectr
UNT
us 4
1545J Am Soc Mass Spectrom 2010, 21, 1534–1546 SPECTRAL COUNTING ERROR STATISTICSSince it is apparent that different rules or thresholds
can affect spectral counting, we implemented three
other counting schemes into PANORAMICS and tested
whether alterations in counting affected variability of
protein counts between replicates. Note that the changes
made were to the counting rules, not to the ways proba-
bilities were determined, meaning that each program
detected the same proteins with the same probabilities but
that the proteins had different summed spectral counts.
The first scheme, ALLCOUNT, counted all spectra as-
signed to peptides regardless of Mascot scoring rank. This
allowed the situation where second, third etc. ranking
matches could be counted. In other words, this allowed
multiple counts per spectrum (up to 10 per spectrum, a
parameter of Mascot) and established the maximum
count possible given the data. The second scheme,
TOPCOUNT, counted spectra to all peptides with a
top-ranking Mascot Ions score regardless the Ions/
Identity score difference, meaning that it would count a
top-ranked match with a very low Mascot score. The
third scheme, IDENTCOUNT, was designed to mimic
as closely as possible within the PANORAMICS frame-
work a Yates lab counting scheme [37]. Counts were
assigned to peptides if the Ions score was top-ranking
and if the Ions/Identity score difference was not less
than zero. In Mascot, if the Ions/Identity score differ-
ence is zero, the false-positive rate for the match is 5%.
Compared with PANORAMICS, ALLCOUNT counted
9000 more spectra, TOPCOUNT 4000 more spec-
tra, and IDENTCOUNT 5000 less spectra on select
single replicate files (Table 1). Thus, it can be seen
that the counting scheme for PANORAMICS results
in a total count that is less than with TOPCOUNT
(counting all of the top ranked peptide spectra in the
Mascot .dat file) but more than with IDENTCOUNT
(counting the top-ranked spectra with Mascot probabil-
ities of 95% or greater than being correct). In other
words, PANORAMICS counts many but not all lower
scoring peptides that may also contribute some reason-
able probability to protein identification.
The effect of the different counts on spectral count
variability was examined between single replicate
files using the G-test, as before. Compared with
PANORAMICS counting, there were more proteins
with significantly different spectral counts using the
ALLCOUNT and TOPCOUNT schemes (Table 3). For
IDENTCOUNT, there were instances where there were
fewer proteins with count variability compared with
PANORAMICS, but there were also instances where
there were more. Generally, as more rigorous thresh-
olds and counting rules were applied, ranging from
counting regardless of match rank or match probability
(ALLCOUNT, least stringent), to counting only top
matches regardless of probability (TOPCOUNT), to
counting only top matches with some probability of
being correct (PANORAMICS), to counting only top
matches with 95% probability of being correct
(IDENTCOUNT, most stringent), the false discovery
rates dropped.However, as the counting thresholds were changed
from weaker to more stringent, the accuracy of ratio
determination for the true positive apotransferrin also
changed (Table 3). Spectral counts for a 1:5 M ratio of
apotransferrin were determined to be significantly dif-
ferent using all counting schemes, but the counts pro-
vided by ALLCOUNT and TOPCOUNT predicted ra-
tios (1 to 3.4 and 1 to 3.1, respectively) slightly smaller
than PANORAMICS (1 to 3.5) whereas the counts from
IDENTCOUNT (1: 5.9) overestimated the true ratio. In
three-way comparisons, spectral counts for 1:5:2 M
ratios of apotransferrin were also significantly diffe-
rent using all counting schemes. But PANORAMICS,
ALLCOUNT and TOPCOUNT counts more closely re-
flected the true molar ratio while IDENTCOUNT over-
estimated the counts with ratios of 1 to 10.6 to 3.8.
The only advantage to the stringent thresholds of
IDENTCOUNT was the ability to statistically resolve
2.8-fold changes, but the sacrifice was over-estimation
for the larger ratios. Therefore, based on these tests,
the original configuration for spectral counting in
PANORAMICS appears to be a sufficient compromise
for obtaining reasonably accurate count ratios between
samples without generating statistically unacceptable
amounts of false differences when low-scoring spectra are
included in the count.
Conclusions
To be beneficial to biology, relative protein quantitation
by label-free tandem mass spectral counting must not
only be able to resolve true protein accumulation
changes between two or more samples, but it must have
a low false discovery rate. Here, we have confirmed
both by evaluating replicate samples of soybean pep-
tides spiked with different molar amounts of bovine
apotransferrin. The numbers of tandem mass spectra
that were collected for apotransferrin increased linearly
with amounts of apotransferrin and the empirical false
discovery rate was nearly the same as the false discov-
ery rate predicted by the Benjamini and Hochberg
correction, a conservative method for calculating q-
values. Since more accurate statistical methods are
available for calculating q-values [38], it is possible to
further limit false discovery rates and improve upon
MudPIT for identifying subtle changes in the accumu-
lation of proteins between samples.
We have also examined four methods for counting
spectra and discovered that changing the count scheme
can influence the false-discovery rate for background
soybean proteins. However, we observed that including
some poorer-scoring spectra improves the accuracy of
measuring molar differences of proteins between sam-
ples. This is likely because including true but poorer-
scoring spectra shifts the observed count toward the
theoretical absolute count. Consequently, the results
also suggest that thresholds for counting can be empir-
ically set to improve relative quantitation using the
label-free method of spectral counting.
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